BioDrugs

The Therapeutic Potential of the Adiponectin Pathway
pp. 1-8(8)
Authors: Gu, Wei; Li, Yang

Briakinumab for the Treatment of Plaque Psoriasis
pp. 9-20(12)
Authors: Traczewski, Pawel; Rudnicka, Lidia

Hybrid Compounds: From Simple Combinations to Nanomachines
pp. 21-31(11)
Authors: Müller-Schiffmann, Andreas; Sticht, Heinrich; Korth, Carsten

Human β-Defensins and Psoriasin/S100A7 Expression in Salivary Glands: Anti-Oncogenic Molecules for Potential Therapeutic Approaches
pp. 33-42(10)
Authors: Kesting, Marco R.; Stoeckelhuber, Mechthild; Kuppek, Alexandra; Hasler, Rafael; Rohleder, Nils; Wolff, Klaus-Dietrich; Nieberler, Markus

Recombinant C1-Inhibitor: Effects on Coagulation and Fibrinolysis in Patients with Hereditary Angioedema
pp. 43-52(10)
Authors: Relan, Anurag; Bakhtiari, Kamran; van Amersfoort, Edwin S.; Meijers, Joost C.M.; Hack, C. Erik

Canakinumab: In Patients with Cryopyrin-Associated Periodic Syndromes
pp. 53-59(7)
Author: Curran, Monique P.

Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia†
pp. 61-64(4)
Authors: McCormack, Paul L.; Keam, Susan J.